News
Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...
The 24-year study of more than 1.2 million children in Denmark found that aluminum exposure didn't raise the risk of autism, asthma, or other chronic diseases. Other science and research news is on ...
The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School ...
Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...
4h
News-Medical.Net on MSNRetrospective analyses indicate Ozempic’s protective effects against stroke fatalityThree studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
Results from this study show that there is a direct correlation between the use of anti-obesity medications and testosterone levels,” the study author said.
2h
Irish Examiner on MSNStill Me: A compassionate guide to dementia careNeuroscientist Sabina Brennan encourages caregivers to live in the moment and notice the happy experiences they share with ...
Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years ...
Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...
Newly published research claims those taking GLP-1 jabs are at a 37 percent lower risk of dementia than those on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results